MedPath

OMEGA OPHTHALMICS

🇺🇸United States
Ownership
-
Established
1848-01-01
Employees
-
Market Cap
-
Website
https://www.omegawatches.com/

Clinical Investigation of Omega Refractive Capsule Model V With Use of an FDA Approved IOL

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: FDA approved Intraocular lens
Device: Omega Refractive Capsule with FDA approved Intraocular Lens
First Posted Date
2020-10-05
Last Posted Date
2022-04-20
Lead Sponsor
Omega Ophthalmics
Target Recruit Count
6
Registration Number
NCT04574102
Locations
🇨🇷

Clinica 20/20, San José, Costa Rica

Clinical Investigation of Omega Refractive Capsule, Model VI

Not Applicable
Active, not recruiting
Conditions
Cataract
Interventions
Device: Omega Refractive Capsule with an FDA approved Intraocular Lens
Device: FDA approved Intraocular Lens
First Posted Date
2020-10-05
Last Posted Date
2023-03-29
Lead Sponsor
Omega Ophthalmics
Target Recruit Count
30
Registration Number
NCT04574115
Locations
🇨🇷

Clinica 20/20, San José, Costa Rica

Comparison of Gemini III Rev 2 Implanted in Conjunction With an Approved IOL vs Eyes Implanted With an Approved IOL

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: Control Eye
Device: Omega Gemini III Rev 2 Device
First Posted Date
2019-08-16
Last Posted Date
2020-09-16
Lead Sponsor
Omega Ophthalmics
Target Recruit Count
6
Registration Number
NCT04059796
Locations
🇨🇷

Clinica 20/20, San José, Costa Rica

Clinical Investigation of OMEGA Gemini Capsule, Model Gemini IV With an Approved Monofocal or Toric IOL

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: Control Eye
Device: Gemini IV
First Posted Date
2019-08-15
Last Posted Date
2020-09-16
Lead Sponsor
Omega Ophthalmics
Target Recruit Count
6
Registration Number
NCT04058314
Locations
🇨🇷

Clinica 20/20, San José, Costa Rica

© Copyright 2025. All Rights Reserved by MedPath